PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Dec-2022 CureVac Members of Management Sell Shares to Cover Tax Obligations from Long Term Incentive Program CureVac
14-Dec-2022 Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture  SAE Media Group
14-Dec-2022 Douglas GmbH: Release of results for the 4th quarter and full year 2021/22 (ending 30 September 2022) on 20 December 2022 Douglas GmbH
14-Dec-2022 Abivax to attend the J.P. Morgan 41st Annual Healthcare Conference ABIVAX
14-Dec-2022 Heidelberg Pharma AG: Encouraging Clinical Data from Two Antibody Drug Conjugates Based on Heidelberg Pharma’s ATAC Technology Presented at the ASH Annual Meeting 2022 Heidelberg Pharma AG
14-Dec-2022 PAION AG convenes extraordinary general meeting for capital reductions by redemption and consolidation of shares PAION AG
14-Dec-2022 Cantourage Group SE: Most potent cannabis flower on the German market: Cantourage launches Miracle Valley’s second product Cantourage Group SE
14-Dec-2022 Apogenix Enrolls First Patients in Pivotal Phase III Trial for the Treatment of Hospitalized COVID-19 Patients with Asunercept Apogenix AG
14-Dec-2022 STORM Therapeutics announces closing of USD $30M Series B financing STORM Therapeutics
14-Dec-2022 Poolbeg exclusively licences innovative oral delivery technology for metabolic syndrome related diseases Poolbeg Pharma
14-Dec-2022 Evolva launches its Natural Nootkatone Evolva Holding SA
14-Dec-2022 Relief Therapeutics to Participate in January Investor Meetings Relief Therapeutics Holding SA
14-Dec-2022 Cosmo announces successful Phase III clinical trial of Lumeblue™ in China Cosmo Pharmaceuticals N.V.
14-Dec-2022 Epigenomics Releases Performance Data on Next Generation Test Epigenomics AG
14-Dec-2022 Epigenomics Licenses Protein Biomarker Technology for Blood-based Colorectal Cancer Test Epigenomics AG
14-Dec-2022 Epigenomics Releases Performance Data on Next Generation Test Epigenomics AG
13-Dec-2022 Scottish Medicines Consortium (SMC) Extends Advice Accepting RINVOQ®▼(upadacitinib) For Treatment of Adults with Moderate Rheumatoid Arthritis AbbVie
13-Dec-2022 Glenmark’s antimalarial wins Highly Commended at Pharmacy MVP Awards Glenmark
13-Dec-2022 DAVID BROCKLEHURST APPOINTED HEAD OF ONCOLOGY AT ASTRAZENECA UK AstraZeneca
13-Dec-2022 Risk of complications and comorbidity higher in South Asian and Black cancer patients compared with population averages across England1 Janssen Pharmaceutical Companies of Johnson & Johnson